They will probably work on creating better GLP-1 and GIP receptor drugs that have fewer side effects, examining the effects of GIP in conjunction with GLP-1
Copper imparts a new therapeutic property to resveratrol by generating ROS to deactivate cell-free chromatin
6 Comparison of G protein coupling between compound 2-bound and GLP-1-bound active GLP-1R in complex with G s
Global Glp 1 Receptor Agonists Obesity Drugs Market Market Size in USD Billion GLP-1 Receptor Agonists Obesity Drugs Market Size The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032 , at a CAGR of 16.21% during the forecast period The market growth is primarily driven by the increasing need for secure, transparent, and tamper-proof systems to manage sensitive healthcare data, billing processes, and patient records across diverse stakeholders In addition, the rising adoption of blockchain technology by healthcare providers, insurers, and pharmaceutical companies to streamline operations, enhance data integrity, and mitigate fraud is propelling market expansion
These are preclinical observations in animal models only
